Risk stratification and outcome of cellulitis admitted to hospital

Journal of Infection

Volumn 60, Issue 6, 2010, Pages 431-439

  Figtree, M ^a   Konecny, P ^b   Jennings, Z ^b   Goh, C ^b   Krilis, S A ^b   Miyakis, S ^c  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Cellulitis; CSSSI; Erysipelas; MRSA; Skin infection; Soft tissue infection

Indexed keywords

ALBUMIN; CIPROFLOXACIN; CLINDAMYCIN; FLUCLOXACILLIN; GENTAMICIN; MEROPENEM; METICILLIN; OXACILLIN; PENICILLIN G; VANCOMYCIN;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY FAILURE; ADULT; AGE; AGED; ANTIBIOTIC RESISTANCE; ARTHRITIS; ARTICLE; BACTEREMIA; BACTERIUM ISOLATION; BURSITIS; CELLULITIS; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE DURATION; ERYSIPELAS; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HUMAN; HYPOALBUMINEMIA; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NEUTROPENIA; NEUTROPHILIA; OUTCOME ASSESSMENT; PSEUDOMONAS AERUGINOSA; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SKIN NECROSIS; SKIN ULCER; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; SUPERINFECTION; SURGICAL DRAINAGE; TERTIARY HEALTH CARE;

AGED; BACTEREMIA; CELLULITIS; ERYSIPELAS; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77953323020     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.03.014     Document Type: Article

References (30)

1. Stevens D.L., Bisno A.L., Chambers H.F., Everett E.D., Dellinger P., Goldstein E.J., et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005, 41(10):1373-1406.
2. Office of population censuses and surveys Morbidity statistics from general practice Fourth National Study 1992, Located at: her majesty's stationery office series MB5 (272).
3. Howden B.P., Grayson M.L. 5: Hospital-in-the-home treatment of infectious diseases. Med J Aust 2002, 176(9):440-445.
4. Australian Institute of Health and Welfare Australian hospital statistics 2005-2006. Health services series no.30. Cat.no.HSE50 2007, AIHW, Canberra, Accessed at, [on 21.04.2009]. http://www.aihw.gov.au/publications/index.cfm/title/10455.
5. Spellberg B., Talbot G.H., Boucher H.W., Bradley J.S., Gilbert D., Scheld W.M., et al. Antimicrobial agents for complicated skin and skin-structure infections: justification of noninferiority margins in the absence of placebo-controlled trials. Clin Infect Dis 2009, 49(3):383-391.
6. Carratala J., Roson B., Fernandez-Sabe N., Shaw E., del Rio O., Rivera A., et al. Factors associated with complications and mortality in adult patients hospitalized for infectious cellulitis. Eur J Clin Microbiol Infect Dis 2003, 22(3):151-157.
7. Goettsch W.G., Bouwes Bavinck J.N., Herings R.M. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol 2006, 20(7):834-839.
8. Bisno A.L., Stevens D.L. Streptococcal infections of skin and soft tissues. N Engl J Med 1996, 334(4):240-245.
9. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med 2003, 31(4):1250-1256.
10. Stevens D.L. Antimicrobial agents for complicated skin and skin-structure infections: noninferiority margins, placebo-controlled trials, and the complexity of clinical trials. Clin Infect Dis 2009, 49(3):392-394.
11. Tan R., Newberry D.J., Arts G.J., Onwuamaegbu M.E. The design, characteristics and predictors of mortality in the North of England Cellulitis Treatment Assessment (NECTA). Int J Clin Pract 2007, 61(11):1889-1893.
12. Corwin P., Toop L., McGeoch G., Than M., Wynn-Thomas S., Wells J.E., et al. Randomised controlled trial of intravenous antibiotic treatment for cellulitis at home compared with hospital. BMJ 2005, 330(7483):129.
13. Morpeth S.C., Chambers S.T., Gallagher K., Frampton C., Pithie A.D. Lower limb cellulitis: features associated with length of hospital stay. J Infect 2006, 52(1):23-29.
14. Cox N.H., Colver G.B., Paterson W.D. Management and morbidity of cellulitis of the leg. J R Soc Med 1998, 91(12):634-637.
15. Aly A.A., Roberts N.M., Seipol K.S., MacLellan D.G. Case survey of management of cellulitis in a tertiary teaching hospital. Med J Aust 1996, 165(10):553-556.
16. Dupuy A., Benchikhi H., Roujeau J.C., Bernard P., Vaillant L., Chosidow O., et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 1999, 318(7198):1591-1594.
17. Leman P., Mukherjee D. Flucloxacillin alone or combined with benzylpenicillin to treat lower limb cellulitis: a randomised controlled trial. Emerg Med J 2005, 22(5):342-346.
18. Gabillot-Carre M., Roujeau J.C. Acute bacterial skin infections and cellulitis. Curr Opin Infect Dis 2007, 20(2):118-123.
19. Bernard P. Management of common bacterial infections of the skin. Curr Opin Infect Dis 2008, 21(2):122-128.
20. Stevens D.L., Gibbons A.E., Bergstrom R., Winn V. The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis 1988, 158(1):23-28.
21. Lazzarini L., Conti E., Tositti G., de Lalla F. Erysipelas and cellulitis: clinical and microbiological spectrum in an Italian tertiary care hospital. J Infect 2005, 51(5):383-389.
22. Epperly T.D. The value of needle aspiration in the management of cellulitis. J Fam Pract 1986, 23(4):337-340.
23. Lebre C., Girard-Pipau F., Roujeau J.C., Revuz J., Saiag P., Chosidow O. Value of fine-needle aspiration in infectious cellulitis. Arch Dermatol 1996, 132(7):842-843.
24. Peralta G., Padron E., Roiz M.P., De Benito I., Garrido J.C., Talledo F., et al. Risk factors for bacteremia in patients with limb cellulitis. Eur J Clin Microbiol Infect Dis 2006, 25(10):619-626.
25. Siljander T., Karppelin M., Vahakuopus S., Syrjanen J., Toropainen M., Kere J., et al. Acute bacterial, nonnecrotizing cellulitis in Finland: microbiological findings. Clin Infect Dis 2008, 46(6):855-861.
26. Stryjewski M.E., Chambers H.F. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008, 46(Suppl. 5):S368-S377.
27. Moellering R.C. A 39-year-old man with a skin infection. JAMA 2008, 299(1):79-87.
28. Fowler V.G., Sanders L.L., Sexton D.J., Kong L., Marr K.A., Gopal A.K., et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998, 27(3):478-486.
29. Rieg S., Peyerl-Hoffmann G., de With K., Theilacker C., Wagner D., Hubner J., et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation - a study of 521 patients in Germany. J Infect 2009, 59(4):232-239.
30. Kitahata M.M., Gange S.J., Abraham A.G., Merriman B., Saag M.S., Justice A.C., et al. Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med 2009, 360(18):1815-1826.